Ambirix Market Report 2026

Ambirix Market Overview

• The Ambirix market growth in the historic period has been driven by global hepatitis burden, childhood vaccination schedules • Market expansion is supported by expanded pediatric coverage, improved vaccine access in emerging markets • Growth Driver: Impact Of Rising Hepatitis Prevalence On The Growth Of The Ambirix Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ambirix Market?

Ambirix is a combined vaccine used to protect against both hepatitis A and hepatitis B infections. It contains inactivated hepatitis A virus and purified hepatitis B surface antigen to stimulate immunity. The vaccine is primarily indicated for individuals aged 1 to 15 years and is administered in a two-dose schedule over six months. It provides long-lasting protection, reducing the risk of severe liver diseases caused by these viruses. The main indication types of ambirix are hepatitis A and hepatitis B. Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus (HAV). The distribution channels are hospitals, pharmacies, and public health programs, and the end users include pediatric and geriatric.

What Is The Ambirix Market Growth Forecast?

The growth in the forecast period can be attributed to expanded pediatric coverage, improved vaccine access in emerging markets, long-term immunity benefits, strengthening public health funding, global hepatitis elimination goals. Major trends in the forecast period include growth of combination vaccines, expansion of pediatric immunization programs, rising focus on hepatitis prevention, improved vaccine compliance through fewer doses, government supported vaccination campaigns.

What Are The Drivers Of The Ambirix Market?

The increasing prevalence of hepatitis infections is expected to propel the growth of the ambirix market going forward. Hepatitis refers to the inflammation of the liver, characterized by damage to liver cells and impairment of its vital functions. Hepatitis, particularly hepatitis A and B, remains a global health concern due to rising infection rates caused by factors such as inadequate sanitation, low vaccination coverage, and increased population mobility. For instance, Ambirix is a combined vaccine used to protect against hepatitis A and B infections in individuals aged 1–15 years, providing long-term immunity with a two-dose schedule. It is particularly recommended in regions with moderate to high infection risks. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in 2023, 17,650 new chronic hepatitis B cases were reported across 44 states and the District of Columbia, representing a prevalence rate of 6.1 cases per 100,000 people. Therefore, the increasing prevalence of hepatitis infections drives the ambirix industry. Growing awareness of pediatric vaccination is expected to boost the growth of the ambirix market going forward. Pediatric vaccination refers to the immunization of children to protect them from infectious diseases, which is critical for reducing the global burden of preventable illnesses. Awareness of pediatric vaccination is increasing due to public health campaigns, school-based immunization programs, and efforts by governments and healthcare organizations to promote immunization benefits. Vaccines such as Ambirix, targeting hepatitis A and B, are essential in safeguarding children’s health and improving vaccination coverage in regions with historically low immunization rates. For instance, in July 2024, according to a report by the World Health Organization, a Switzerland-based health authority, global coverage of the first dose of HPV vaccine among girls rose significantly to 27% in 2023, up from 20% in 2022, driven by new introductions in several countries and the adoption of a 1-dose schedule. Therefore, growing awareness of pediatric vaccination will drive the ambirix industry. The rising healthcare expenditure is expected to accelerate the growth of the ambirix market going forward. Healthcare expenditure refers to the allocation of financial resources toward health services, including vaccination programs and access to combined hepatitis A and B vaccines. Healthcare expenditure refers to the total spending on medical services, goods, and public health initiatives aimed at maintaining and improving health. Ambirix contributes to healthcare expenditure by reducing long-term treatment costs associated with hepatitis A and B through effective prevention. Its use supports cost-efficient public health strategies. For instance, in May 2024, according to a report published by Office For National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, rising healthcare expenditure drives the ambirix industry.

Key Players In The Global Ambirix Market

Major companies operating in the ambirix market are GSK plc

What Defines the Ambirix Market?

The ambirix market consists of sales of single-pack doses, multi-pack doses of pre-filled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ambirix Market Report 2026?

The ambirix market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ambirix industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.